The Terrible, Horrible, No Good, Very Bad Pharma Day* A challenge You are passionate about providing an intervention (drug or device) to a group… September 29, 2015 Uncategorized
Blood: Underappreciated Resource in the Health/Disease? Alternative title: Pitching a VC on Disruption of Blood Testing You may have seen… May 5, 2015 Uncategorized
Case Study: When does “technology” turn into medical device This semester I've embarked on an adventure to co-teach a class in the University… February 8, 2015 Uncategorized
What is the optimal biotech burn rate? Ethan Perlstein, founder of Perlstein Lab, asked a question on Twitter and got some great… February 2, 2015 Uncategorized
US Biosimilars Pathway – A Step Closer to Reality Today Sandoz announced that their Biologics License Application for filgrastim was accepted by the… July 24, 2014 Uncategorized
Silos in Drug Development I was in Chicago last month for the American Society of Clinical Oncology (ASCO)… July 16, 2013 Uncategorized
Drug Development & the User Experience What is Tech UX? I was recently at a local event for entrepreneurs (thanks… December 7, 2012 Uncategorized